WESTBURY, NY / ACCESSWIRE / November 13, 2014 / Vasomedical, Inc. (VASO), a diversified medical technology company specializing in the design, manufacture and sale of medical devices, today announced that, for the third consecutive year, it has been named on the Deloitte’s Technology Fast 500(TM) list, with a ranking of 166, up from 207 last year.

The Deloitte’s Technology Fast 500(TM) is a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. The ranking is based on percentage growth of annual revenue from 2009 to 2013, during which Vasomedical’s growth rate was 636%.

“We are proud to be named on this prestigious list three years in a row, which clearly indicates the success the Company has made in the right direction,” commented Dr. Jun Ma, President and CEO of Vasomedical, Inc., upon receiving the award. “We will continue to execute the business strategy we have embarked on in our effort to build value for our shareholders.”

“The companies ranked on the 2014 Deloitte Technology Fast 500 continue to set the bar for their industry higher each year,” said Eric Openshaw, vice chairman, Deloitte LLP and U.S. technology, media and telecommunications leader. “There are so many exciting products and smart thought leaders driving this list. We congratulate the Fast 500 companies and look forward to seeing them continue their momentum into 2015.”

About Vasomedical

Vasomedical, Inc. is a diversified medical technology company specializing in the manufacture and sale of medical devices and in the domestic sale of diagnostic imaging products. The Company operates through four wholly owned subsidiaries: Vasomedical Solutions, Inc., Vasomedical Global Corp., Vaso Diagnostics, Inc. d.b.a. VasoHealthcare, and VasoHealthcare IT Corp. Vasomedical Solutions manages and coordinates the design, manufacture and sales of EECP(R) Therapy systems and other medical equipment operations; Vasomedical Global operates the Company’s China-based subsidiaries; VasoHealthcare is the operating subsidiary for the exclusive sales representation of GE Healthcare diagnostic imaging products in certain market segments; and VasoHealthcare IT is a national value added reseller of GE Healthcare IT’s Radiology PACS (Picture Archiving and Communication System) software solutions and related services, including implementation, management and support. Additional information is available on the Company’s website at http://www.vasomedical.com/.

Investor Contacts:

Michael J. Beecher/Amanda Jiang
Investor Relations
Phone: 516-508-5840
Email: mbeecher@vasomedical.com / ajiang@vasomedical.com

SOURCE: Vasomedical, Inc.

Link to Yahoo Finance: http://finance.yahoo.com/news/vasomedical-ranked-number-166-deloittes-153000273.html